demecolcine and Bloom-Syndrome

Bloom's syndrome (BS) is a rare human autosomal recessive disorder characterized by an increased risk to develop cancer of all types. BS cells are characterized by a generalized genetic instability including a high level of sister chromatid exchanges. BS arises through mutations in both alleles of the BLM gene which encodes a 3' - 5' DNA helicase identified as a member of the RecQ family. We developed polyclonal antibodies specific for the NH2- and COOH-terminal region of BLM. Using these antibodies, we analysed BLM expression during the cell cycle and showed that the BLM protein accumulates to high levels in S phase, persists in G2/M and sharply declines in G1, strongly suggestive of degradation during mitosis. The BLM protein is subject to post-translational modifications in mitosis, as revealed by slow migrating forms of BLM found in both demecolcine-treated cells and in mitotic cells isolated from non-treated asynchronous populations. Phosphatase treatment indicated that phosphorylation events were solely responsible for the appearance of the retarded moieties, a possible signal for subsequent degradation. Together, these results are consistent with a role of BLM in a replicative (S phase) and/or post-replicative (G2 phase) process. Oncogene (2000).

Topics: Adenosine Triphosphatases; Bloom Syndrome; Demecolcine; DNA Helicases; G2 Phase; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Mitosis; Peptide Hydrolases; Phosphorylation; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; RecQ Helicases; S Phase; Tumor Cells, Cultured

Single and twin sister chromatid exchanges (SCEs) were analysed in the colcemid-induced endoreduplicated normal and Bloom syndrome (BS) B-lymphoid cells with diplochromosomes. In normal cells, an equal number of SCEs occur in each of the two cell cycles; the ratio of single (= 5.51 SCEs/cell) to twins (= 2.64 SCEs/cell) was 2:1 on the endoreduplicated-cell basis, and it was 1:1 on the diploid-cell basis. In contrast, in 29 endomitoses from one BS B-lymphoid line, a manyfold increase of single SCEs was detected and 139.4 single SCEs on the average were counted, whereas twin SCEs were rare and only 4.9 twin SCEs were countable. In BS cells, the ratio of single (= 139.4 SCEs/cell) to twins (4.9 SCEs/cell) was 28:1 on the endoreduplicated-cell basis, and it was 14:1 on the diploid cell-basis; the rates of S1 and S2 exchanges were 4.9 and 69.7 SCEs/cell, respectively. The present study strongly indicates that most of BS SCEs occur during the second cell cycle when BrdU-containing DNA is used as template for replication and that BrdU enhances BS SCEs.

Topics: B-Lymphocytes; Bloom Syndrome; Cells, Cultured; Demecolcine; Humans; Mitosis; Sister Chromatid Exchange